

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | chaperone-mediated protein transport (GO:0072321) | 5.44999363 |
| 2 | protein neddylation (GO:0045116) | 5.08268034 |
| 3 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.77643424 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.58906502 |
| 5 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.43506114 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 4.38651103 |
| 7 | ATP synthesis coupled proton transport (GO:0015986) | 4.17053949 |
| 8 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.17053949 |
| 9 | rRNA modification (GO:0000154) | 3.94885105 |
| 10 | cellular response to zinc ion (GO:0071294) | 3.80439394 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.78308723 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.75396185 |
| 13 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.75310130 |
| 14 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.74885585 |
| 15 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.68905830 |
| 16 | sequestering of actin monomers (GO:0042989) | 3.64575805 |
| 17 | rRNA methylation (GO:0031167) | 3.61842543 |
| 18 | DNA deamination (GO:0045006) | 3.60714638 |
| 19 | * respiratory electron transport chain (GO:0022904) | 3.60664184 |
| 20 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.55433572 |
| 21 | * electron transport chain (GO:0022900) | 3.50382845 |
| 22 | protein deneddylation (GO:0000338) | 3.45854960 |
| 23 | proteasome assembly (GO:0043248) | 3.42715016 |
| 24 | protein complex biogenesis (GO:0070271) | 3.42577105 |
| 25 | cullin deneddylation (GO:0010388) | 3.42347575 |
| 26 | viral transcription (GO:0019083) | 3.37738159 |
| 27 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.36232012 |
| 28 | NADH dehydrogenase complex assembly (GO:0010257) | 3.36232012 |
| 29 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.36232012 |
| 30 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.34561659 |
| 31 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.33570120 |
| 32 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.32189932 |
| 33 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.29795234 |
| 34 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.29795234 |
| 35 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.29264601 |
| 36 | translational termination (GO:0006415) | 3.27736716 |
| 37 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.23751879 |
| 38 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.23751879 |
| 39 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.23751879 |
| 40 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.22655944 |
| 41 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.21187324 |
| 42 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.20773517 |
| 43 | protein localization to mitochondrion (GO:0070585) | 3.20591815 |
| 44 | platelet dense granule organization (GO:0060155) | 3.19711022 |
| 45 | oxidative phosphorylation (GO:0006119) | 3.18677065 |
| 46 | cotranslational protein targeting to membrane (GO:0006613) | 3.17912594 |
| 47 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.17610536 |
| 48 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.17480497 |
| 49 | negative regulation of ligase activity (GO:0051352) | 3.17480497 |
| 50 | iron-sulfur cluster assembly (GO:0016226) | 3.15830399 |
| 51 | metallo-sulfur cluster assembly (GO:0031163) | 3.15830399 |
| 52 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.13589567 |
| 53 | daunorubicin metabolic process (GO:0044597) | 3.12610038 |
| 54 | polyketide metabolic process (GO:0030638) | 3.12610038 |
| 55 | doxorubicin metabolic process (GO:0044598) | 3.12610038 |
| 56 | protein targeting to ER (GO:0045047) | 3.12492408 |
| 57 | translational elongation (GO:0006414) | 3.06643451 |
| 58 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.06391009 |
| 59 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.06391009 |
| 60 | ribosomal small subunit biogenesis (GO:0042274) | 3.03694204 |
| 61 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.03602703 |
| 62 | respiratory chain complex IV assembly (GO:0008535) | 3.02754033 |
| 63 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.01095083 |
| 64 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.99879067 |
| 65 | protein localization to endoplasmic reticulum (GO:0070972) | 2.99761991 |
| 66 | cellular response to interferon-beta (GO:0035458) | 2.98756779 |
| 67 | pseudouridine synthesis (GO:0001522) | 2.95707059 |
| 68 | base-excision repair, AP site formation (GO:0006285) | 2.95348226 |
| 69 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.94253442 |
| 70 | neutrophil activation involved in immune response (GO:0002283) | 2.92562868 |
| 71 | cytochrome complex assembly (GO:0017004) | 2.91548492 |
| 72 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.90476046 |
| 73 | response to interferon-beta (GO:0035456) | 2.89142153 |
| 74 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.85845849 |
| 75 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.85845849 |
| 76 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.85674795 |
| 77 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.84019844 |
| 78 | purine nucleotide salvage (GO:0032261) | 2.81710824 |
| 79 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.81534192 |
| 80 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.80538582 |
| 81 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.80098777 |
| 82 | inner mitochondrial membrane organization (GO:0007007) | 2.80068049 |
| 83 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.79970643 |
| 84 | mannosylation (GO:0097502) | 2.79230136 |
| 85 | translation (GO:0006412) | 2.78548287 |
| 86 | protein targeting to mitochondrion (GO:0006626) | 2.78064017 |
| 87 | hydrogen ion transmembrane transport (GO:1902600) | 2.77712342 |
| 88 | heart process (GO:0003015) | 2.77675301 |
| 89 | heart contraction (GO:0060047) | 2.77675301 |
| 90 | signal peptide processing (GO:0006465) | 2.76516993 |
| 91 | autophagic vacuole fusion (GO:0000046) | 2.75988883 |
| 92 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.75143817 |
| 93 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.74809647 |
| 94 | aerobic respiration (GO:0009060) | 2.74549028 |
| 95 | DNA double-strand break processing (GO:0000729) | 2.72245725 |
| 96 | establishment of protein localization to mitochondrion (GO:0072655) | 2.71990351 |
| 97 | deoxyribonucleotide catabolic process (GO:0009264) | 2.71250217 |
| 98 | organelle membrane fusion (GO:0090174) | 2.68560412 |
| 99 | GTP biosynthetic process (GO:0006183) | 2.68071066 |
| 100 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.67142752 |
| 101 | defense response to protozoan (GO:0042832) | 2.66819019 |
| 102 | cellular component biogenesis (GO:0044085) | 2.66736704 |
| 103 | mitochondrial transport (GO:0006839) | 2.64916241 |
| 104 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.64355462 |
| 105 | termination of RNA polymerase III transcription (GO:0006386) | 2.64355462 |
| 106 | positive regulation of ligase activity (GO:0051351) | 2.64124704 |
| 107 | regulation of B cell differentiation (GO:0045577) | 2.64061848 |
| 108 | regulation of cellular amine metabolic process (GO:0033238) | 2.63987360 |
| 109 | C-terminal protein lipidation (GO:0006501) | 2.63615887 |
| 110 | positive regulation of macrophage differentiation (GO:0045651) | 2.63445592 |
| 111 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.63443228 |
| 112 | cytidine deamination (GO:0009972) | 2.63270765 |
| 113 | cytidine metabolic process (GO:0046087) | 2.63270765 |
| 114 | cytidine catabolic process (GO:0006216) | 2.63270765 |
| 115 | tRNA processing (GO:0008033) | 2.63126607 |
| 116 | cellular protein complex disassembly (GO:0043624) | 2.63111233 |
| 117 | viral life cycle (GO:0019058) | 2.62895216 |
| 118 | proton transport (GO:0015992) | 2.62882352 |
| 119 | deoxyribose phosphate catabolic process (GO:0046386) | 2.62357053 |
| 120 | L-methionine salvage (GO:0071267) | 2.62260950 |
| 121 | L-methionine biosynthetic process (GO:0071265) | 2.62260950 |
| 122 | amino acid salvage (GO:0043102) | 2.62260950 |
| 123 | nucleoside salvage (GO:0043174) | 2.61492546 |
| 124 | regulation of mitochondrial translation (GO:0070129) | 2.61348060 |
| 125 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.60962481 |
| 126 | positive regulation of cell cycle arrest (GO:0071158) | 2.60326093 |
| 127 | ribosomal large subunit biogenesis (GO:0042273) | 2.59899424 |
| 128 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.59614340 |
| 129 | telomere maintenance via recombination (GO:0000722) | 2.59413680 |
| 130 | hydrogen transport (GO:0006818) | 2.58446418 |
| 131 | translational initiation (GO:0006413) | 2.58220807 |
| 132 | tricarboxylic acid cycle (GO:0006099) | 2.58059998 |
| 133 | intracellular protein transmembrane import (GO:0044743) | 2.58048585 |
| 134 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.57848418 |
| 135 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.57560975 |
| 136 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.57018725 |
| 137 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.55754271 |
| 138 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.55584357 |
| 139 | purine-containing compound salvage (GO:0043101) | 2.55455517 |
| 140 | T cell migration (GO:0072678) | 2.55151843 |
| 141 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.54096270 |
| 142 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.54096270 |
| 143 | ATP biosynthetic process (GO:0006754) | 2.51802601 |
| 144 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.51708018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.84484783 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.83728004 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.81835908 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.78401939 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.68797944 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.57890058 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.33668279 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.32391561 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.12743186 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.03169158 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.91668895 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.83054240 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.82416650 |
| 14 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.77527388 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.72607217 |
| 16 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.68281794 |
| 17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.54238952 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.53247753 |
| 19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.52051199 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.51315555 |
| 21 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.47894708 |
| 22 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.46112767 |
| 23 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.29492639 |
| 24 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.19432428 |
| 25 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.13905351 |
| 26 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.13768531 |
| 27 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.10524738 |
| 28 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10487773 |
| 29 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.06052056 |
| 30 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.05596444 |
| 31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.05170763 |
| 32 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.03975176 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.96267488 |
| 34 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.95038774 |
| 35 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.89010889 |
| 36 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.86943683 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.80872490 |
| 38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.79403548 |
| 39 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76141991 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75130261 |
| 41 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.74983958 |
| 42 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.72998756 |
| 43 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.70385676 |
| 44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.65726123 |
| 45 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.64624451 |
| 46 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.64259667 |
| 47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.54041352 |
| 48 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.49578153 |
| 49 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.48655542 |
| 50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.45650735 |
| 51 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.44124610 |
| 52 | VDR_22108803_ChIP-Seq_LS180_Human | 1.43160984 |
| 53 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41624521 |
| 54 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.40862021 |
| 55 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.38571510 |
| 56 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.38352835 |
| 57 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37826188 |
| 58 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.37767552 |
| 59 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.36109265 |
| 60 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.35277655 |
| 61 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.29594369 |
| 62 | MYB_26560356_Chip-Seq_TH2_Human | 1.29033806 |
| 63 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.27553380 |
| 64 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.26105872 |
| 65 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.25852952 |
| 66 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.23931820 |
| 67 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.23413717 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.23313582 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22961905 |
| 70 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.22681769 |
| 71 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.20962312 |
| 72 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.18940447 |
| 73 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.18373995 |
| 74 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.16845853 |
| 75 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.13896401 |
| 76 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.13185768 |
| 77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11151118 |
| 78 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.10018609 |
| 79 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.08355696 |
| 80 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.08248661 |
| 81 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06898793 |
| 82 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.06563219 |
| 83 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05997969 |
| 84 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.04874419 |
| 85 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.04804277 |
| 86 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.03580157 |
| 87 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03502622 |
| 88 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02343508 |
| 89 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.01998689 |
| 90 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.01839844 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01257815 |
| 92 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.01029088 |
| 93 | MYB_26560356_Chip-Seq_TH1_Human | 1.00363222 |
| 94 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99803329 |
| 95 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.98760254 |
| 96 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97916640 |
| 97 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.97383764 |
| 98 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.96767391 |
| 99 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.95800965 |
| 100 | MAF_26560356_Chip-Seq_TH1_Human | 0.94536745 |
| 101 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94246403 |
| 102 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93962062 |
| 103 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.93888161 |
| 104 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.93285286 |
| 105 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92959445 |
| 106 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.92815893 |
| 107 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.92561365 |
| 108 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92507102 |
| 109 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.92492872 |
| 110 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.91622177 |
| 111 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91104422 |
| 112 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.90540698 |
| 113 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.89578341 |
| 114 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.89079854 |
| 115 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.88799315 |
| 116 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88615822 |
| 117 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.88362876 |
| 118 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.87146704 |
| 119 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85197138 |
| 120 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.83895976 |
| 121 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.83756107 |
| 122 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.83712557 |
| 123 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.83706376 |
| 124 | AR_20517297_ChIP-Seq_VCAP_Human | 0.83412161 |
| 125 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.78927333 |
| 126 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.78375976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.14781772 |
| 2 | MP0005671_abnormal_response_to | 3.62610847 |
| 3 | MP0009785_altered_susceptibility_to | 3.55615832 |
| 4 | MP0000685_abnormal_immune_system | 2.91960047 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 2.69607062 |
| 6 | MP0005000_abnormal_immune_tolerance | 2.61925281 |
| 7 | MP0001800_abnormal_humoral_immune | 2.46621336 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.42379993 |
| 9 | MP0003436_decreased_susceptibility_to | 2.42014479 |
| 10 | MP0005025_abnormal_response_to | 2.41978786 |
| 11 | MP0005084_abnormal_gallbladder_morpholo | 2.40058725 |
| 12 | MP0006036_abnormal_mitochondrial_physio | 2.39590517 |
| 13 | MP0001790_abnormal_immune_system | 2.38827880 |
| 14 | MP0005387_immune_system_phenotype | 2.38827880 |
| 15 | MP0003646_muscle_fatigue | 2.29131628 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.28684988 |
| 17 | MP0003724_increased_susceptibility_to | 2.26797613 |
| 18 | MP0002723_abnormal_immune_serum | 2.25217944 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.24125759 |
| 20 | MP0001819_abnormal_immune_cell | 2.21945141 |
| 21 | MP0003656_abnormal_erythrocyte_physiolo | 2.12858189 |
| 22 | MP0001853_heart_inflammation | 2.12625099 |
| 23 | MP0002398_abnormal_bone_marrow | 2.08152840 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 2.05187412 |
| 25 | MP0003186_abnormal_redox_activity | 2.03032536 |
| 26 | MP0002419_abnormal_innate_immunity | 1.98352132 |
| 27 | MP0006082_CNS_inflammation | 1.93617911 |
| 28 | MP0002166_altered_tumor_susceptibility | 1.88153950 |
| 29 | MP0000716_abnormal_immune_system | 1.88015783 |
| 30 | MP0005075_abnormal_melanosome_morpholog | 1.87341776 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.81394880 |
| 32 | MP0003786_premature_aging | 1.81058858 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.75067784 |
| 34 | MP0002722_abnormal_immune_system | 1.74868131 |
| 35 | MP0002163_abnormal_gland_morphology | 1.74716211 |
| 36 | MP0002405_respiratory_system_inflammati | 1.73606818 |
| 37 | MP0004147_increased_porphyrin_level | 1.73300468 |
| 38 | MP0002429_abnormal_blood_cell | 1.65463589 |
| 39 | MP0002102_abnormal_ear_morphology | 1.61264128 |
| 40 | MP0003011_delayed_dark_adaptation | 1.60853341 |
| 41 | MP0003806_abnormal_nucleotide_metabolis | 1.55615872 |
| 42 | MP0006035_abnormal_mitochondrial_morpho | 1.53965759 |
| 43 | MP0001529_abnormal_vocalization | 1.53626972 |
| 44 | MP0000343_altered_response_to | 1.53493448 |
| 45 | MP0008469_abnormal_protein_level | 1.53413844 |
| 46 | MP0008877_abnormal_DNA_methylation | 1.51621963 |
| 47 | MP0005310_abnormal_salivary_gland | 1.50108164 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.49987464 |
| 49 | MP0002396_abnormal_hematopoietic_system | 1.49007414 |
| 50 | MP0001984_abnormal_olfaction | 1.45471861 |
| 51 | MP0003693_abnormal_embryo_hatching | 1.45082665 |
| 52 | MP0009697_abnormal_copulation | 1.43730946 |
| 53 | MP0002277_abnormal_respiratory_mucosa | 1.39903636 |
| 54 | MP0004215_abnormal_myocardial_fiber | 1.35288574 |
| 55 | MP0001873_stomach_inflammation | 1.34599372 |
| 56 | MP0008872_abnormal_physiological_respon | 1.31920641 |
| 57 | MP0002006_tumorigenesis | 1.31812037 |
| 58 | MP0006054_spinal_hemorrhage | 1.30237916 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.30069937 |
| 60 | MP0003866_abnormal_defecation | 1.29289776 |
| 61 | MP0010386_abnormal_urinary_bladder | 1.27068539 |
| 62 | MP0003718_maternal_effect | 1.26350298 |
| 63 | MP0000858_altered_metastatic_potential | 1.25040958 |
| 64 | MP0002132_abnormal_respiratory_system | 1.24632226 |
| 65 | MP0001348_abnormal_lacrimal_gland | 1.22729193 |
| 66 | MP0005379_endocrine/exocrine_gland_phen | 1.20992355 |
| 67 | MP0004957_abnormal_blastocyst_morpholog | 1.20089108 |
| 68 | MP0003123_paternal_imprinting | 1.20088583 |
| 69 | MP0005058_abnormal_lysosome_morphology | 1.19826770 |
| 70 | MP0000749_muscle_degeneration | 1.19810845 |
| 71 | MP0004133_heterotaxia | 1.19065402 |
| 72 | MP0004510_myositis | 1.18931218 |
| 73 | MP0005645_abnormal_hypothalamus_physiol | 1.18000122 |
| 74 | MP0000490_abnormal_crypts_of | 1.17755112 |
| 75 | MP0010155_abnormal_intestine_physiology | 1.16335571 |
| 76 | MP0002254_reproductive_system_inflammat | 1.15929568 |
| 77 | MP0010094_abnormal_chromosome_stability | 1.15517820 |
| 78 | MP0004142_abnormal_muscle_tone | 1.14743186 |
| 79 | MP0002653_abnormal_ependyma_morphology | 1.14252729 |
| 80 | MP0009765_abnormal_xenobiotic_induced | 1.14161356 |
| 81 | MP0008057_abnormal_DNA_replication | 1.13645064 |
| 82 | MP0003195_calcinosis | 1.13264190 |
| 83 | MP0001533_abnormal_skeleton_physiology | 1.12270373 |
| 84 | MP0004084_abnormal_cardiac_muscle | 1.12058047 |
| 85 | MP0008875_abnormal_xenobiotic_pharmacok | 1.11587864 |
| 86 | MP0009764_decreased_sensitivity_to | 1.10743699 |
| 87 | MP0001764_abnormal_homeostasis | 1.10695737 |
| 88 | MP0002933_joint_inflammation | 1.10277865 |
| 89 | MP0000703_abnormal_thymus_morphology | 1.09142203 |
| 90 | MP0008789_abnormal_olfactory_epithelium | 1.00852323 |
| 91 | MP0004036_abnormal_muscle_relaxation | 1.00803390 |
| 92 | MP0006072_abnormal_retinal_apoptosis | 1.00649259 |
| 93 | MP0009379_abnormal_foot_pigmentation | 0.98835882 |
| 94 | MP0003221_abnormal_cardiomyocyte_apopto | 0.98801173 |
| 95 | MP0003183_abnormal_peptide_metabolism | 0.98557760 |
| 96 | MP0005636_abnormal_mineral_homeostasis | 0.97595164 |
| 97 | MP0002693_abnormal_pancreas_physiology | 0.97084539 |
| 98 | MP0002019_abnormal_tumor_incidence | 0.96477674 |
| 99 | MP0000358_abnormal_cell_content/ | 0.95660822 |
| 100 | MP0001919_abnormal_reproductive_system | 0.94742122 |
| 101 | MP0001905_abnormal_dopamine_level | 0.94714755 |
| 102 | MP0002095_abnormal_skin_pigmentation | 0.92657578 |
| 103 | MP0003077_abnormal_cell_cycle | 0.92033314 |
| 104 | MP0005410_abnormal_fertilization | 0.91792541 |
| 105 | MP0004808_abnormal_hematopoietic_stem | 0.90280568 |
| 106 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89570732 |
| 107 | MP0008007_abnormal_cellular_replicative | 0.89189077 |
| 108 | MP0009763_increased_sensitivity_to | 0.87140439 |
| 109 | MP0001545_abnormal_hematopoietic_system | 0.86639688 |
| 110 | MP0005397_hematopoietic_system_phenotyp | 0.86639688 |
| 111 | MP0005389_reproductive_system_phenotype | 0.83916329 |
| 112 | MP0003787_abnormal_imprinting | 0.83609135 |
| 113 | MP0001986_abnormal_taste_sensitivity | 0.83432627 |
| 114 | MP0002736_abnormal_nociception_after | 0.82240301 |
| 115 | MP0004947_skin_inflammation | 0.81408655 |
| 116 | MP0003303_peritoneal_inflammation | 0.80657387 |
| 117 | MP0008995_early_reproductive_senescence | 0.79356921 |
| 118 | MP0008004_abnormal_stomach_pH | 0.77385777 |
| 119 | MP0001756_abnormal_urination | 0.76528629 |
| 120 | MP0001663_abnormal_digestive_system | 0.76378278 |
| 121 | MP0003111_abnormal_nucleus_morphology | 0.75850732 |
| 122 | MP0008058_abnormal_DNA_repair | 0.75446611 |
| 123 | MP0000013_abnormal_adipose_tissue | 0.72234187 |
| 124 | MP0008775_abnormal_heart_ventricle | 0.71007328 |
| 125 | MP0000465_gastrointestinal_hemorrhage | 0.70389662 |
| 126 | MP0005174_abnormal_tail_pigmentation | 0.69504268 |
| 127 | MP0008932_abnormal_embryonic_tissue | 0.69282345 |
| 128 | MP0005319_abnormal_enzyme/_coenzyme | 0.68582269 |
| 129 | MP0000015_abnormal_ear_pigmentation | 0.66555815 |
| 130 | MP0002876_abnormal_thyroid_physiology | 0.65535941 |
| 131 | MP0005166_decreased_susceptibility_to | 0.64025946 |
| 132 | MP0008873_increased_physiological_sensi | 0.63223317 |
| 133 | MP0000372_irregular_coat_pigmentation | 0.62771472 |
| 134 | MP0005266_abnormal_metabolism | 0.62159188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.15583377 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.05892927 |
| 3 | Mitochondrial inheritance (HP:0001427) | 4.61203752 |
| 4 | Hepatocellular necrosis (HP:0001404) | 4.37766790 |
| 5 | Progressive macrocephaly (HP:0004481) | 4.27154119 |
| 6 | Acute encephalopathy (HP:0006846) | 4.23806003 |
| 7 | Increased CSF lactate (HP:0002490) | 4.11234567 |
| 8 | Hepatic necrosis (HP:0002605) | 4.06594140 |
| 9 | Increased intramyocellular lipid droplets (HP:0012240) | 3.82744393 |
| 10 | Increased hepatocellular lipid droplets (HP:0006565) | 3.75060441 |
| 11 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.74966879 |
| 12 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.74966879 |
| 13 | Lipid accumulation in hepatocytes (HP:0006561) | 3.71370618 |
| 14 | Increased muscle lipid content (HP:0009058) | 3.65094762 |
| 15 | Exertional dyspnea (HP:0002875) | 3.64453551 |
| 16 | Exercise intolerance (HP:0003546) | 3.36225903 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.28802932 |
| 18 | Increased serum lactate (HP:0002151) | 3.23024235 |
| 19 | Cerebral edema (HP:0002181) | 3.21935429 |
| 20 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.19503450 |
| 21 | Lactic acidosis (HP:0003128) | 3.17661922 |
| 22 | Stomatitis (HP:0010280) | 3.03843176 |
| 23 | Abnormal number of erythroid precursors (HP:0012131) | 3.00436994 |
| 24 | Recurrent abscess formation (HP:0002722) | 2.99505342 |
| 25 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.99407827 |
| 26 | Respiratory failure (HP:0002878) | 2.94165103 |
| 27 | 3-Methylglutaconic aciduria (HP:0003535) | 2.92994508 |
| 28 | Renal Fanconi syndrome (HP:0001994) | 2.92492596 |
| 29 | Abnormality of alanine metabolism (HP:0010916) | 2.91509676 |
| 30 | Hyperalaninemia (HP:0003348) | 2.91509676 |
| 31 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.91509676 |
| 32 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.88564101 |
| 33 | IgM deficiency (HP:0002850) | 2.80354200 |
| 34 | Recurrent bronchitis (HP:0002837) | 2.77335216 |
| 35 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.73243873 |
| 36 | Thrombocytosis (HP:0001894) | 2.72525906 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 2.72158911 |
| 38 | Reduced antithrombin III activity (HP:0001976) | 2.67736116 |
| 39 | Gastrointestinal stroma tumor (HP:0100723) | 2.64634316 |
| 40 | Respiratory difficulties (HP:0002880) | 2.62604863 |
| 41 | Cerebral hemorrhage (HP:0001342) | 2.59504711 |
| 42 | Abnormality of glycolysis (HP:0004366) | 2.58602509 |
| 43 | Increased serum pyruvate (HP:0003542) | 2.58602509 |
| 44 | Agammaglobulinemia (HP:0004432) | 2.57907986 |
| 45 | Methylmalonic aciduria (HP:0012120) | 2.53428147 |
| 46 | Recurrent bacterial skin infections (HP:0005406) | 2.46073665 |
| 47 | Pheochromocytoma (HP:0002666) | 2.45409984 |
| 48 | * Neuroendocrine neoplasm (HP:0100634) | 2.45409984 |
| 49 | Neoplasm of head and neck (HP:0012288) | 2.42439093 |
| 50 | Esophageal neoplasm (HP:0100751) | 2.42439093 |
| 51 | Reticulocytopenia (HP:0001896) | 2.39174172 |
| 52 | Type I transferrin isoform profile (HP:0003642) | 2.38932172 |
| 53 | Chronic otitis media (HP:0000389) | 2.37287015 |
| 54 | Optic disc pallor (HP:0000543) | 2.35571638 |
| 55 | Abnormality of renal resorption (HP:0011038) | 2.32978634 |
| 56 | IgG deficiency (HP:0004315) | 2.29953509 |
| 57 | Petechiae (HP:0000967) | 2.26581473 |
| 58 | Decreased central vision (HP:0007663) | 2.25523247 |
| 59 | Severe combined immunodeficiency (HP:0004430) | 2.24654448 |
| 60 | Aplastic anemia (HP:0001915) | 2.24127654 |
| 61 | Autoimmune hemolytic anemia (HP:0001890) | 2.23223528 |
| 62 | Glycosuria (HP:0003076) | 2.21177381 |
| 63 | Abnormality of urine glucose concentration (HP:0011016) | 2.21177381 |
| 64 | Methylmalonic acidemia (HP:0002912) | 2.20831094 |
| 65 | Molar tooth sign on MRI (HP:0002419) | 2.18293423 |
| 66 | Abnormality of midbrain morphology (HP:0002418) | 2.18293423 |
| 67 | CNS demyelination (HP:0007305) | 2.17128305 |
| 68 | Vasculitis (HP:0002633) | 2.16924430 |
| 69 | Leukodystrophy (HP:0002415) | 2.16842798 |
| 70 | Abnormality of T cells (HP:0002843) | 2.15670148 |
| 71 | Palpitations (HP:0001962) | 2.14877656 |
| 72 | Gastrointestinal infarctions (HP:0005244) | 2.13946604 |
| 73 | Abnormality of T cell number (HP:0011839) | 2.12316999 |
| 74 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.10465924 |
| 75 | Lymphopenia (HP:0001888) | 2.09653507 |
| 76 | Neutropenia (HP:0001875) | 2.08933461 |
| 77 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.08339785 |
| 78 | Generalized aminoaciduria (HP:0002909) | 2.08330570 |
| 79 | Progressive microcephaly (HP:0000253) | 2.07815473 |
| 80 | Abnormality of T cell physiology (HP:0011840) | 2.06785324 |
| 81 | Poor head control (HP:0002421) | 2.06309161 |
| 82 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.06180176 |
| 83 | Chronic sinusitis (HP:0011109) | 2.06035226 |
| 84 | Pancytopenia (HP:0001876) | 2.05927603 |
| 85 | Abnormal protein glycosylation (HP:0012346) | 2.05295683 |
| 86 | Abnormal glycosylation (HP:0012345) | 2.05295683 |
| 87 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.05295683 |
| 88 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.05295683 |
| 89 | Increased IgM level (HP:0003496) | 2.04891923 |
| 90 | Recurrent viral infections (HP:0004429) | 2.03918347 |
| 91 | Microvesicular hepatic steatosis (HP:0001414) | 2.03596745 |
| 92 | Conjunctival hamartoma (HP:0100780) | 2.02187678 |
| 93 | Pallor (HP:0000980) | 2.01235783 |
| 94 | Emotional lability (HP:0000712) | 1.99350273 |
| 95 | Combined immunodeficiency (HP:0005387) | 1.98897393 |
| 96 | Birth length less than 3rd percentile (HP:0003561) | 1.98325255 |
| 97 | Fatigue (HP:0012378) | 1.96105415 |
| 98 | Renal cortical cysts (HP:0000803) | 1.95346633 |
| 99 | T lymphocytopenia (HP:0005403) | 1.90925426 |
| 100 | Rhabdomyolysis (HP:0003201) | 1.90459844 |
| 101 | Macrocytic anemia (HP:0001972) | 1.90281234 |
| 102 | Lethargy (HP:0001254) | 1.90036304 |
| 103 | Oral leukoplakia (HP:0002745) | 1.89844858 |
| 104 | Leukocytosis (HP:0001974) | 1.89129127 |
| 105 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.89045449 |
| 106 | Dicarboxylic aciduria (HP:0003215) | 1.89045449 |
| 107 | Abnormality of B cell number (HP:0010975) | 1.88791059 |
| 108 | B lymphocytopenia (HP:0010976) | 1.88791059 |
| 109 | Granulocytopenia (HP:0001913) | 1.87821048 |
| 110 | Nausea (HP:0002018) | 1.87415437 |
| 111 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.87402975 |
| 112 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.86239191 |
| 113 | Hepatosplenomegaly (HP:0001433) | 1.85353831 |
| 114 | Type 2 muscle fiber atrophy (HP:0003554) | 1.84584478 |
| 115 | Eczematoid dermatitis (HP:0000976) | 1.83632650 |
| 116 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.83079242 |
| 117 | Degeneration of anterior horn cells (HP:0002398) | 1.82993413 |
| 118 | Abnormality of the anterior horn cell (HP:0006802) | 1.82993413 |
| 119 | Recurrent fungal infections (HP:0002841) | 1.82856490 |
| 120 | Autoimmune thrombocytopenia (HP:0001973) | 1.82456111 |
| 121 | Purpura (HP:0000979) | 1.81849808 |
| 122 | Cerebral hypomyelination (HP:0006808) | 1.80806703 |
| 123 | Prolonged neonatal jaundice (HP:0006579) | 1.78447038 |
| 124 | Pancreatic cysts (HP:0001737) | 1.77536745 |
| 125 | Abnormality of macrophages (HP:0004311) | 1.77222021 |
| 126 | Abolished electroretinogram (ERG) (HP:0000550) | 1.77125598 |
| 127 | True hermaphroditism (HP:0010459) | 1.76576826 |
| 128 | Amaurosis fugax (HP:0100576) | 1.76484192 |
| 129 | Abnormality of serum amino acid levels (HP:0003112) | 1.73709031 |
| 130 | Pancreatic fibrosis (HP:0100732) | 1.73214149 |
| 131 | Abnormality of magnesium homeostasis (HP:0004921) | 1.70958022 |
| 132 | Abnormal pupillary function (HP:0007686) | 1.70641259 |
| 133 | Hypothermia (HP:0002045) | 1.70550161 |
| 134 | Hyperglycinemia (HP:0002154) | 1.68546918 |
| 135 | Hypomagnesemia (HP:0002917) | 1.66240601 |
| 136 | Medial flaring of the eyebrow (HP:0010747) | 1.66024878 |
| 137 | Congenital stationary night blindness (HP:0007642) | 1.64678847 |
| 138 | Muscle fiber atrophy (HP:0100295) | 1.64418688 |
| 139 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.64162157 |
| 140 | Nephronophthisis (HP:0000090) | 1.62355622 |
| 141 | X-linked dominant inheritance (HP:0001423) | 1.60816254 |
| 142 | Abnormality of the labia minora (HP:0012880) | 1.60066509 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 3.67971988 |
| 2 | STK16 | 3.47901376 |
| 3 | NME2 | 3.12879377 |
| 4 | PIM2 | 2.88819220 |
| 5 | MST4 | 2.84177670 |
| 6 | NUAK1 | 2.74878053 |
| 7 | EIF2AK1 | 2.69976152 |
| 8 | MAP3K12 | 2.66314231 |
| 9 | TBK1 | 2.41818902 |
| 10 | ARAF | 2.37647940 |
| 11 | TESK2 | 2.31896192 |
| 12 | PIK3CG | 2.25891360 |
| 13 | IRAK4 | 2.25740099 |
| 14 | EIF2AK3 | 2.19738014 |
| 15 | BUB1 | 2.18055317 |
| 16 | MAP4K1 | 2.14971733 |
| 17 | MAP3K14 | 2.13616311 |
| 18 | MAP4K2 | 2.12128157 |
| 19 | BLK | 1.91977888 |
| 20 | TAOK3 | 1.84510959 |
| 21 | IKBKE | 1.74984237 |
| 22 | KDR | 1.72501995 |
| 23 | SCYL2 | 1.72040947 |
| 24 | ACVR1B | 1.71219660 |
| 25 | BCKDK | 1.66040574 |
| 26 | KIT | 1.61059802 |
| 27 | TYK2 | 1.58849499 |
| 28 | TEC | 1.58188436 |
| 29 | TLK1 | 1.57526021 |
| 30 | ZAP70 | 1.56466482 |
| 31 | MAP3K13 | 1.53442054 |
| 32 | MYLK | 1.52691057 |
| 33 | TXK | 1.44056372 |
| 34 | TESK1 | 1.43532487 |
| 35 | BTK | 1.43402757 |
| 36 | SYK | 1.42722176 |
| 37 | CDK19 | 1.40294799 |
| 38 | RPS6KA4 | 1.32477272 |
| 39 | WEE1 | 1.30933710 |
| 40 | JAK3 | 1.28232883 |
| 41 | CDC7 | 1.26925725 |
| 42 | LIMK1 | 1.25264438 |
| 43 | WNK3 | 1.24820709 |
| 44 | IKBKB | 1.24672250 |
| 45 | MAPKAPK3 | 1.24364522 |
| 46 | BMPR1B | 1.24353060 |
| 47 | NME1 | 1.22427048 |
| 48 | VRK1 | 1.21164916 |
| 49 | GRK6 | 1.18563877 |
| 50 | PLK3 | 1.16280701 |
| 51 | TRIM28 | 1.15819958 |
| 52 | CAMKK2 | 1.09782791 |
| 53 | BRSK2 | 1.09331257 |
| 54 | LYN | 1.06294438 |
| 55 | PDK2 | 1.06193307 |
| 56 | ILK | 1.03554402 |
| 57 | NEK9 | 1.02572201 |
| 58 | DYRK2 | 1.01955325 |
| 59 | GRK1 | 0.98678128 |
| 60 | RAF1 | 0.93335690 |
| 61 | MARK3 | 0.92515863 |
| 62 | TNIK | 0.91050741 |
| 63 | CSNK1G3 | 0.90510402 |
| 64 | OBSCN | 0.90229875 |
| 65 | RIPK4 | 0.89249817 |
| 66 | MAP3K11 | 0.88996090 |
| 67 | LCK | 0.88878409 |
| 68 | ITK | 0.87592170 |
| 69 | CCNB1 | 0.86565529 |
| 70 | STK24 | 0.85797361 |
| 71 | FRK | 0.81939388 |
| 72 | LRRK2 | 0.81184503 |
| 73 | PDK3 | 0.79837141 |
| 74 | PDK4 | 0.79837141 |
| 75 | MUSK | 0.77989822 |
| 76 | PLK4 | 0.73874446 |
| 77 | PIM1 | 0.72795508 |
| 78 | PBK | 0.72518725 |
| 79 | CSNK1G2 | 0.71485427 |
| 80 | TAOK2 | 0.69781687 |
| 81 | ERN1 | 0.69741225 |
| 82 | PRKCQ | 0.68158621 |
| 83 | TSSK6 | 0.66953944 |
| 84 | CSNK1G1 | 0.66369934 |
| 85 | PLK1 | 0.65522312 |
| 86 | DYRK3 | 0.65286898 |
| 87 | MAP2K7 | 0.64999354 |
| 88 | WNK4 | 0.64072065 |
| 89 | DAPK3 | 0.63871632 |
| 90 | SRPK1 | 0.63386268 |
| 91 | ADRBK2 | 0.61391671 |
| 92 | OXSR1 | 0.61198929 |
| 93 | GRK7 | 0.58075613 |
| 94 | JAK1 | 0.57407318 |
| 95 | GRK5 | 0.56371344 |
| 96 | MAP2K3 | 0.56187527 |
| 97 | PLK2 | 0.55636788 |
| 98 | FLT3 | 0.55022422 |
| 99 | CDK8 | 0.54992087 |
| 100 | BRAF | 0.54814028 |
| 101 | DAPK1 | 0.54193255 |
| 102 | PASK | 0.52870409 |
| 103 | MAP2K6 | 0.52811619 |
| 104 | PHKG2 | 0.51543099 |
| 105 | PHKG1 | 0.51543099 |
| 106 | EIF2AK2 | 0.50356353 |
| 107 | BRSK1 | 0.48586411 |
| 108 | CSNK1A1L | 0.48353857 |
| 109 | IRAK3 | 0.47833600 |
| 110 | ADRBK1 | 0.47353271 |
| 111 | ABL2 | 0.45879326 |
| 112 | CSF1R | 0.45286572 |
| 113 | PRKCD | 0.45216529 |
| 114 | NEK1 | 0.45091807 |
| 115 | TGFBR1 | 0.43959472 |
| 116 | MATK | 0.43713387 |
| 117 | MAP2K2 | 0.43358368 |
| 118 | STK4 | 0.43268851 |
| 119 | MAP3K5 | 0.43040834 |
| 120 | FES | 0.40563209 |
| 121 | CSK | 0.40435242 |
| 122 | MAPK13 | 0.40421292 |
| 123 | PRKCI | 0.39227948 |
| 124 | ATR | 0.39136817 |
| 125 | TTN | 0.37670566 |
| 126 | MAPKAPK5 | 0.37201885 |
| 127 | RPS6KB2 | 0.35966364 |
| 128 | CSNK2A1 | 0.35697519 |
| 129 | MAPK12 | 0.34494394 |
| 130 | STK10 | 0.33803465 |
| 131 | TRPM7 | 0.33007065 |
| 132 | CSNK2A2 | 0.31476733 |
| 133 | RPS6KA5 | 0.30197953 |
| 134 | RPS6KA6 | 0.26246645 |
| 135 | ZAK | 0.25311149 |
| 136 | TNK2 | 0.24584563 |
| 137 | BMPR2 | 0.24582038 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.49045536 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.78628797 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.70847555 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.40864566 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 2.77741200 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.59361943 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.50464979 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.45785354 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.37021736 |
| 10 | Alzheimers disease_Homo sapiens_hsa05010 | 2.27555594 |
| 11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.27147086 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.26249040 |
| 13 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.22531965 |
| 14 | Huntingtons disease_Homo sapiens_hsa05016 | 2.22098982 |
| 15 | Mismatch repair_Homo sapiens_hsa03430 | 2.14114712 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.08566315 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 1.95632546 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.95601680 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.75517288 |
| 20 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.64168813 |
| 21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.55992902 |
| 22 | Homologous recombination_Homo sapiens_hsa03440 | 1.54517944 |
| 23 | Base excision repair_Homo sapiens_hsa03410 | 1.49935407 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.47561150 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.41568474 |
| 26 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.39807483 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.25336101 |
| 28 | Spliceosome_Homo sapiens_hsa03040 | 1.22280774 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.22226569 |
| 30 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.21681209 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.19898616 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.18583264 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.18179972 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.17595380 |
| 35 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.16511600 |
| 36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.13592408 |
| 37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.12368017 |
| 38 | Leishmaniasis_Homo sapiens_hsa05140 | 1.11607375 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10153328 |
| 40 | Purine metabolism_Homo sapiens_hsa00230 | 1.08135790 |
| 41 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.04215742 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.04203502 |
| 43 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.03685143 |
| 44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.03076198 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.02631687 |
| 46 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.99542213 |
| 47 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.97939348 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.96254145 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.94792389 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.94627803 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.94258024 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.93991541 |
| 53 | Asthma_Homo sapiens_hsa05310 | 0.90969744 |
| 54 | RNA degradation_Homo sapiens_hsa03018 | 0.89308138 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88809738 |
| 56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.88615217 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.88361829 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88165186 |
| 59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.88120971 |
| 60 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.87878495 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86742599 |
| 62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.86731493 |
| 63 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85549173 |
| 64 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81786769 |
| 65 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.77005046 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76549101 |
| 67 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.75347423 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.73926921 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73145043 |
| 70 | RNA transport_Homo sapiens_hsa03013 | 0.72809502 |
| 71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72712114 |
| 72 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72566056 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.71866858 |
| 74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.69763209 |
| 75 | Phagosome_Homo sapiens_hsa04145 | 0.69480481 |
| 76 | Apoptosis_Homo sapiens_hsa04210 | 0.69081729 |
| 77 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.66240565 |
| 78 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.65750610 |
| 79 | Basal transcription factors_Homo sapiens_hsa03022 | 0.65605836 |
| 80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61492082 |
| 81 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.61278280 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60670954 |
| 83 | Malaria_Homo sapiens_hsa05144 | 0.60115730 |
| 84 | Tuberculosis_Homo sapiens_hsa05152 | 0.58760954 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58391774 |
| 86 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57127223 |
| 87 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.56951680 |
| 88 | Pertussis_Homo sapiens_hsa05133 | 0.56533232 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.56418217 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.56004852 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55885084 |
| 92 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.55215505 |
| 93 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.53942065 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.50442468 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49965567 |
| 96 | Phototransduction_Homo sapiens_hsa04744 | 0.49476005 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49466924 |
| 98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.49095790 |
| 99 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.48497740 |
| 100 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.48396067 |
| 101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.48275991 |
| 102 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.47298218 |
| 103 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47183433 |
| 104 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.45039486 |
| 105 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.44615002 |
| 106 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.44532552 |
| 107 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.43638538 |
| 108 | Influenza A_Homo sapiens_hsa05164 | 0.42388222 |
| 109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42284830 |
| 110 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42213827 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42080830 |
| 112 | Cell cycle_Homo sapiens_hsa04110 | 0.41157055 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40759259 |
| 114 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.39955197 |
| 115 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.39604411 |
| 116 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.39356501 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39348683 |
| 118 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.38845725 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38782902 |
| 120 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.38451305 |
| 121 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38084835 |
| 122 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36889609 |
| 123 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.36263008 |
| 124 | Lysosome_Homo sapiens_hsa04142 | 0.34037296 |
| 125 | Hepatitis B_Homo sapiens_hsa05161 | 0.33962610 |
| 126 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33322473 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31424482 |
| 128 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.30715561 |
| 129 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.30702400 |
| 130 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.30275303 |

